About CryoLife

bldg smallCryoLife, Inc. is one of the world’s contemporary medical device companies providing preserved human cardiac and vascular tissues, surgical adhesives and sealants, cardiac lasers and implantable end-stage renal disease access grafts for the repair of complex cardiac and vascular reconstruction surgeries. Since the Company’s inception in 1984, it is estimated that its products and tissues have been implanted in about 900,000 patients worldwide.

Learn More

Products and Services

vid-cardiac Cardiac Tissues
Aortic and pulmonary homografts for cardiac reconstruction
vid-vascular Vascular Tissues
Allografts for AV access, peripheral bypass, and infected fields
vid-hero HeRO® Graft
AV access solution to reduce catheter dependency
vid-bioglue BioGlue® Surgical Adhesive
The leading surgical adhesive used in cardiovascular surgery
vid-tmr Transmyocardial Revascularization
Laser therapy for ischemic heart disease
vid-perclot Perclot®
Next generation hemostat for international use only

Learn More


A TMR Patient’s Story - Theresa
Theresa has had a long history with coronary disease and has undergone multiple therapies for her condition including emergency bypass surgery. In spite of benefitting from those procedures, she suffered from debilitating chronic angina. TMR is a clinically proven laser therapy procedure for chronic angina patients refractory to medical treatment.

Learn More

Recent News

CryoLife Announces Release Date and Teleconference Call Details for 2014 Second Quarter Financial Results

CryoLife announced today that 2014 second quarter financial results will be released on Thursday, July 24, 2014. On that day, the Company will hold a teleconference call and live webcast at 10:00 a.m. Eastern Time to discuss the results, followed by a question and answer session hosted by Steven G. Anderson, president and chief executive officer of CryoLife, Inc.

Learn More

CryoLife Appoints Pat Mackin as President and Chief Executive Officer

CryoLife announced today that its Board of Directors has appointed James Patrick (Pat) Mackin, age 47, as President and Chief Executive Officer, effective September 2, 2014. Mr. Mackin is expected to be appointed to the Company's Board of Directors after his employment begins.

Learn More

New Clinical Update from the National Kidney Foundation

Read how cryopreserved allografts can effectively manage infected AV grafts. Download the National Kidney Foundation's clinical update for more information.

Learn More

Become a Donor and “Light Up the World”

30yrsEach year, the Donate Life Rose Parade Float serves as a memorial to organ and tissue donors, their families, living donors, and transplant recipients. This year’s theme, Light Up the World, represents the compassion and courage of those who give and receive the gift of life. Adorning the float, Donate Life America gave tribute to 81 donors with their own floragraph while 36 recipients and living donors were honored with positions to ride or walk in the parade.

CryoLife was given the exceptional privilege to announce Kevin Patrick Dobson as one of the donors to be memorialized with a floragraph. Kevin was known for his dedication and drive to help those in need. His greatest source of pride was his children, his son Kevin Patrick Dobson, Jr., daughters Jamie Kathleen and Brooke Lauren Dobson, and step-son Andrew Hastings. While serving his community as a New York State Trooper, he was struck by a passing motorist. According to his father Richard, “Kevin prayed that his donation would lessen the suffering of another family. We who loved him in life know that his prayer was answered.”

Learn More

Quilted Tributes to Honor Donors


CryoLife is kicking off a three month campaign to display a donor quilt each month, beginning April 1, 2014, in honor of Donate Life Month.

Learn More